Journal ArticleJ Cardiovasc Electrophysiol · October 15, 2024
INTRODUCTION: Conduction system pacing (CSP), often accomplished with lumenless pacing leads, is increasingly employed to achieve physiologic ventricular activation. There are limited data on the extraction of these leads. The objective of this study was t ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · September 28, 2024
BACKGROUND: Data on whether cardiac resynchronization therapy (CRT) results in better clinical and echocardiographic outcomes in patients with nonischemic cardiomyopathy (NICM) vs ischemic cardiomyopathy (ICM) are conflicting. OBJECTIVES: The authors condu ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · August 6, 2024
BACKGROUND: Data on the benefits of cardiac resynchronization therapy (CRT) in patients with severe heart failure symptoms are limited. We investigated the relative effects of CRT in patients with ambulatory New York Heart Association (NYHA) IV versus III ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · June 2024
BACKGROUND: Women might benefit more than men from cardiac resynchronization therapy (CRT) and do so at shorter QRS durations. OBJECTIVE: This meta-analysis was performed to determine whether sex-based differences in CRT effects are better accounted for by ...
Full textLink to itemCite
Journal ArticleCirc Genom Precis Med · June 2024
BACKGROUND: Substantial data support a heritable basis for supraventricular tachycardias, but the genetic determinants and molecular mechanisms of these arrhythmias are poorly understood. We sought to identify genetic loci associated with atrioventricular ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · May 2024
INTRODUCTION: Peak frequency (PF) mapping is a novel method that may identify critical portions of myocardial substrate supporting reentry. The aim of this study was to describe and evaluate PF mapping combined with omnipolar voltage mapping in the identif ...
Full textLink to itemCite
Journal ArticleCirc Arrhythm Electrophysiol · April 2024
BACKGROUND: The National Cardiovascular Data Registry Left Atrial Appendage Occlusion Registry (LAAO) includes the vast majority of transcatheter LAAO procedures performed in the United States. The objective of this study was to develop a model predicting ...
Full textLink to itemCite
Journal ArticleEur Heart J · March 27, 2024
Patients with severe mental illness (SMI) including schizophrenia and bipolar disorder die on average 15-20 years earlier than the general population often due to sudden death that, in most cases, is caused by cardiovascular disease. This state-of-the-art ...
Full textLink to itemCite
Journal ArticleAm Heart J · January 2024
BACKGROUND: Cardiac resynchronization therapy (CRT) reduces heart failure hospitalizations (HFH) and mortality for guideline-indicated patients with heart failure (HF). Most patients with HF are aged ≥70 years but such patients are often under-represented ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · October 2023
BACKGROUND: Left ventricular (LV) lead implantation is often the most challenging aspect of cardiac resynchronization therapy (CRT) procedures; early studies reported implant failure rates in ∼10% of cases. OBJECTIVE: The purpose of this study was to defin ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · September 2023
AIMS: To investigate the association of cardiac resynchronization therapy (CRT) on outcomes among participants with and without a history of atrial fibrillation (AF). METHODS: Individual-patient-data from four randomized trials investigating CRT-Defibrilla ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · August 15, 2023
Background There is uncertainty about the appropriate use of primary prevention implantable cardioverter-defibrillators (ICDs) among older patients with hypertrophic cardiomyopathy. Methods and Results Patients with hypertrophic cardiomyopathy who received ...
Full textLink to itemCite
Journal ArticlemedRxiv · July 6, 2023
Data on the benefits of cardiac resynchronization therapy (CRT) in patients with severe heart failure (HF) symptoms are limited. We investigated the relative effects of CRT in patients with ambulatory NYHA IV vs. III functional class at the time of device ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · July 2023
INTRODUCTION: Transvenous implantable cardioverter-defibrillator (ICD) shocks have been associated with cardiac biomarker elevations and are thought in some cases to contribute to adverse clinical outcomes and mortality, possibly from myocardium exposed to ...
Full textLink to itemCite
Journal ArticleJACC Cardiovasc Interv · June 12, 2023
BACKGROUND: The impact of preprocedure imaging on the safety and effectiveness of left atrial appendage occlusion (LAAO) remains unclear. OBJECTIVES: This study sought to determine the rates of use of preprocedure computed tomography (CT)/cardiac magnetic ...
Full textLink to itemCite
Journal ArticleJAMA network open · June 2023
ImportanceAlthough reduced doses of direct oral anticoagulants (DOACs) are approved for patients with nonvalvular atrial fibrillation (NVAF) at high risk of bleeding, little is known about dosing accuracy, particularly in patients with renal dysfu ...
Full textCite
Journal ArticleHeart Rhythm O2 · May 2023
BACKGROUND: Catheter ablation is recommended for the treatment of symptomatic atrial fibrillation (AF) refractory to medical therapy. OBJECTIVE: The study sought to examine racial/ethnic and sex differences in complications and AF/atrial flutter (AFL)-rela ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · May 2023
INTRODUCTION: Incomplete anchoring of the Watchman left atrial appendage closure (LAAO) device can result in substantial device migration or device embolization (DME) requiring percutaneous or surgical retrieval. METHODS: We performed a retrospective analy ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · April 2023
INTRODUCTION: Although atrial fibrillation (AF) ablation has become increasingly safer, rehospitalization and emergency department (ED) evaluations can occur in the postablation period. Better understanding of the frequency, causes, and predictors for hosp ...
Full textLink to itemCite
Journal ArticleHeart · March 27, 2023
OBJECTIVE: Older, relatively small studies identified female sex as a risk factor for adverse events after catheter ablation for atrial fibrillation (AF). We aimed to assess contemporary sex-based differences in baseline and procedural characteristics, adv ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · March 2023
BACKGROUND: The electrocardiographic (ECG) marker P terminal force V1 (PTFV1) is generally perceived as a marker of left atrial pathology and has been associated with atrial fibrillation or flutter (AF). OBJECTIVE: The purpose of this study was to determin ...
Full textLink to itemCite
Journal ArticleCirculation · March 2023
BackgroundBenefit from cardiac resynchronization therapy (CRT) varies by QRS characteristics; individual randomized trials are underpowered to assess benefit for relatively small subgroups.MethodsThe authors analyzed patient-level data fr ...
Full textCite
Journal ArticleClinicoecon Outcomes Res · 2023
BACKGROUND: Atrial fibrillation (AF) is associated with considerable morbidity and mortality. Timely management and treatment is critical in alleviating AF disease burden. Variation in treatment by race and ethnic and sex could lead to inequities in health ...
Full textLink to itemCite
Journal ArticleAm Heart J · December 2022
BACKGROUND: Clinical events committee (CEC) evaluation is the standard approach for end point adjudication in clinical trials. Due to resource constraints, large registries typically rely on site-reported end points without further confirmation, which may ...
Full textLink to itemCite
Journal ArticleCirc Cardiovasc Interv · December 2022
BACKGROUND: Left atrial appendage occlusion is an important alternative to anticoagulation in select patients with nonvalvular atrial fibrillation. Trends in real-world device sizing and associated short-term complications have not been characterized. METH ...
Full textLink to itemCite
Journal ArticleJACC Clin Electrophysiol · December 2022
BACKGROUND: Peak-to-peak bipolar voltage varies with electrode orientation, fractionation, and collision events. Novel, omnipolar mapping is less dependent on electrode orientation but has limited data in humans. OBJECTIVES: This study sought to compare bi ...
Full textLink to itemCite
Journal ArticleJACC. Cardiovascular interventions · November 2022
BackgroundProcedural complications limit the clinical benefit of transcatheter left atrial appendage occlusion (LAAO). Next-generation devices incorporate design modifications intended to improve procedural safety, but their clinical impact has no ...
Full textCite
Journal ArticleCurr Cardiol Rep · August 2022
PURPOSE OF REVIEW: While the subcutaneous (S-) implantable cardioverter-defibrillator (ICDs) is an alternative to the transvenous (TV-) ICD in many patients, optimal use remains unclear. In this review, we summarize recent clinically relevant data on sensi ...
Full textLink to itemCite
Journal ArticleCirc Cardiovasc Qual Outcomes · August 2022
BACKGROUND: The Food and Drug Administration approved left atrial appendage occlusion with the Watchman device for patients who are at increased stroke risk and are suitable for oral anticoagulation but who have an appropriate reason to seek a nondrug alte ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · May 10, 2022
BACKGROUND: Pivotal trials of percutaneous left atrial appendage occlusion (LAAO) used specific postprocedure treatment protocols. OBJECTIVES: This study sought to evaluate patterns of postprocedure care after LAAO with the Watchman device in clinical prac ...
Full textLink to itemCite
Journal ArticleJACC Cardiovasc Interv · May 9, 2022
OBJECTIVES: The aim of this study was to compare outcomes among patients from the PROTECT-AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial Fibrillation) and PREVAIL (Evaluation of the WATCHMAN Left Atrial Appendage [ ...
Full textLink to itemCite
Journal ArticleCirc Cardiovasc Interv · May 2022
BACKGROUND: Pericardial effusion (PE) is a potential complication of transcatheter left atrial appendage occlusion. The objective of this study was to investigate the incidence, associated characteristics, and outcomes of PE following left atrial appendage ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · March 22, 2022
BACKGROUND: The subcutaneous (S-) implantable cardioverter-defibrillator (ICD) is an alternative to the transvenous (TV-) ICD that is increasingly implanted in younger patients; data on the safety and effectiveness of the S-ICD in older patients are lackin ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · March 2022
OBJECTIVES: This study sought to assess the comparative effectiveness of cardiac resynchronization therapy with defibrillator (CRT-D) over implantable cardioverter-defibrillator (ICD) alone in older Medicare patients with heart failure with reduced ejectio ...
Full textLink to itemCite
Journal ArticleCardiol J · 2022
BACKGROUND: Many patients in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) had a significant improvement (> 10%) in the left ventricular ejection fraction (LVEF) during the course of the study, but the factors and outcomes associated with such ...
Full textLink to itemCite
Journal ArticleHeart Rhythm O2 · December 2021
BACKGROUND: Although lesion transmurality is required for durable pulmonary vein isolation, excess ablation is associated with increased risk of complications. OBJECTIVE: We sought to understand the impact of interrupted radiofrequency (RF) delivery condit ...
Full textLink to itemCite
Journal ArticleBMJ Surgery, Interventions, and Health Technologies · December 1, 2021
Objectives To determine the feasibility of using real-world data to assess the safety and effectiveness of two cardiac ablation catheters for the treatment of persistent atrial fibrillation and ischaemic ventricular tachycardia. Design Retrospective cohort ...
Full textCite
Journal ArticlePacing Clin Electrophysiol · November 2021
BACKGROUND: Despite changes inthe legality of cannabis use and the increasing prevalence of cannabis use disorder (CUD), there is little data investigating the association between CUD and inpatient atrial fibrillation (AF) hospitalizations. METHODS: Using ...
Full textLink to itemCite
Journal ArticleJournal of electrocardiology · November 2021
BackgroundQRS duration and morphology including left bundle branch block (LBBB) are the most widely used electrocardiogram (ECG) markers for assessing ventricular dyssynchrony and predicting heart failure (HF). However, the vectorcardiographic QRS ...
Full textCite
Journal ArticleCirc Heart Fail · October 2021
BACKGROUND: Patients with severe mental illness (SMI) including schizophrenia, bipolar disorder, and severe depression have earlier onset of cardiovascular risk factors, predisposing to worse future heart failure (HF) compared with the general population. ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · September 2021
The left atrial posterior wall has many embryologic, anatomic, and electrophysiologic characteristics, that are important for the initiation and maintenance of persistent atrial fibrillation. The left atrial posterior wall is a potential target for ablatio ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · August 2021
BACKGROUND: Ventricular arrhythmias (VAs) and electrical storm (ES) are recognized complications following left ventricular assist device (LVAD) implantation; however, their association with long term-outcomes remains poorly understood. OBJECTIVE: The purp ...
Full textLink to itemCite
Journal ArticleCirc Cardiovasc Imaging · July 2021
BACKGROUND: Patients with a class I recommendation for cardiac resynchronization therapy (CRT) are likely to benefit, but the effect of CRT in class II patients is more heterogeneous and additional selection parameters are needed in this group. The recentl ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · June 2021
Background Heart failure (HF) and atrial fibrillation (AF) frequently coexist and may be associated with worse HF outcomes, but there is limited contemporary evidence describing their combined prevalence. We examined current trends in AF among hospitalizat ...
Full textLink to itemCite
ConferenceJ Thorac Cardiovasc Surg · April 2021
BACKGROUND: This study compares outcomes of patients with preoperative atrial fibrillation undergoing coronary artery bypass grafting (CABG) with or without concomitant atrial fibrillation ablation in a nationally representative Medicare cohort. OBJECTIVES ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · February 2021
INTRODUCTION: Cryoballoon ablation (CBA) is an alternative to radiofrequency ablation (RFA) for ablation of atrial fibrillation (AF) and real-world comparisons of this strategy are lacking. As such, we sought to compare patient and periprocedural character ...
Full textLink to itemCite
Journal ArticleHeart rhythm O2 · February 2021
BackgroundAblation reduces atrial fibrillation (AF) burden and improves health-related quality of life. The relationship between ablation, healthcare utilization, and AF type (paroxysmal AF [PAF] vs persistent AF [PsAF]) remains unclear.Object ...
Full textCite
Journal ArticleJ Am Heart Assoc · January 19, 2021
Background ECG abnormalities are associated with adverse outcomes in the general population, but their prognostic significance in severe mental illness (SMI) remains unexplored. We investigated associations between no, minor, and major ECG abnormalities an ...
Full textLink to itemCite
Journal ArticleAm Heart J · January 2021
BACKGROUND: Few therapies improve outcomes in patients with heart failure with preserved ejection fraction (HFpEF). If left bundle-branch block (LBBB) is associated with left ventricular dyssynchrony and impaired cardiac performance in HFpEF, cardiac resyn ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · December 15, 2020
Left bundle branch block (LBBB) increases the likelihood of developing reduced left ventricular (LV) ejection fraction (EF) but predicting which patients with LBBB and normal LVEF will develop decreased LVEF remains challenging. Fifty patients with LBBB an ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · December 2020
BACKGROUND: Catheter ablation is an effective treatment for patients with atrial fibrillation (AF) and heart failure (HF). However, little is known about how healthcare utilization and cost change after ablation in this population. We sought to determine h ...
Full textLink to itemCite
Journal ArticleClin J Am Soc Nephrol · November 6, 2020
BACKGROUND AND OBJECTIVES: Patients on dialysis are at high risk of complications related to implantable cardioverter defibrillator (ICD) implantation; use of subcutaneous ICDs may be preferred over transvenous devices due to lower risk of bloodstream infe ...
Full textLink to itemCite
Journal ArticlePacing Clin Electrophysiol · November 2020
BACKGROUND: Biventricular (BiV) pacing increases transmural repolarization heterogeneity due to epicardial to endocardial conduction from the left ventricular (LV) lead. However, limited evidence is available on concomitant changes in ventricular depolariz ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · October 15, 2020
Data is lacking on the contemporary risk of death and readmission following implantable cardioverter-defibrillator (ICD) implantation in patients with non-ischemic cardiomyopathies (NICM) compared with ischemic cardiomyopathies (ICM) in a large nationally ...
Full textLink to itemCite
Journal ArticleHeart Rhythm O2 · October 2020
BACKGROUND: Women seem to derive more benefit from cardiac resynchronization therapy (CRT) than men, even after accounting for the higher burden of risk factors for nonresponse often observed in men. OBJECTIVE: To assess for sex-specific differences in lef ...
Full textLink to itemCite
Journal ArticleUltrasound Med Biol · September 2020
The real time high frame rate (HFR) 2-dimensional ultrasound system, T5, at Duke University is capable of imaging at up to 1000 images per second for adult cardiac imaging. A method for detecting and visualizing the mechanical contraction fronts using HFR ...
Full textLink to itemCite
Journal ArticlePacing Clin Electrophysiol · September 2020
BACKGROUND: Cardiac amyloidosis is a progressive infiltrative disease involving deposition of amyloid fibrils in the myocardium and cardiac conduction system that frequently manifests with heart failure (HF) and arrhythmias, most frequently atrial fibrilla ...
Full textLink to itemCite
Journal ArticleJACC Clin Electrophysiol · September 2020
OBJECTIVES: This study sought to determine the indications, characteristics, and outcomes of cardiovascular implantable electronic device (CIED) surgery in patients with LVAD. BACKGROUND: Many patients with a left ventricular assist device (LVAD) will requ ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · August 2020
BACKGROUND: During catheter ablation, delivery of radiofrequency (RF) energy to a target site is sometimes interrupted by catheter instability and clinical factors. The impact of interruption of RF delivery on lesion characteristics has not been characteri ...
Full textLink to itemCite
Journal ArticleJAMA Cardiol · June 1, 2020
IMPORTANCE: Little is known about the utilization rates and outcomes of implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) placement among patients with advanced heart failure (HF). OBJECTIVE: To examin ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · June 2020
INTRODUCTION: Lead dysfunction can lead to serious consequences including failure to treat ventricular tachycardia or fibrillation (VT/VF). The incidence and mechanisms of lead dysfunction following left ventricular assist device (LVAD) implantation are no ...
Full textLink to itemCite
Journal ArticleJACC. Clinical electrophysiology · June 2020
ObjectivesThis study identified factors associated with risk for cardiac perforation in the setting of atrial fibrillation (AF) ablation in contemporary clinical practice.BackgroundCardiac perforation is an uncommon but potentially fatal ...
Full textCite
Journal ArticleAm J Med · May 2020
BACKGROUND: The Fourth Universal Definition of Myocardial Infarction defines electrocardiographic Q waves as duration ≥30 ms and amplitude ≥1 mm or QS complex in 2 contiguous leads. However, current taskforce criteria may be overly restrictive. Therefore, ...
Full textLink to itemCite
Journal ArticlePacing Clin Electrophysiol · May 2020
BACKGROUND: A low electrocardiogram (ECG) lead one ratio (LOR) of the maximum positive/negative QRS amplitudes is associated with lower left ventricular ejection fraction (LVEF) and worse outcomes in left bundle branch block (LBBB); however, the impact of ...
Full textLink to itemCite
Journal ArticleJ Interv Card Electrophysiol · April 2020
PURPOSE: Patients with atrial fibrillation (AF) undergoing cardiac surgery are at substantially increased risk for stroke. Increasing evidence has suggested that surgical left atrial appendage occlusion (S-LAAO) may have the potential to substantially miti ...
Full textLink to itemCite
Journal ArticleJ Arrhythm · April 2020
BACKGROUND: Focal impulse and rotor modulation (FIRM) can cause slowing, organization, and occasionally termination of atrial fibrillation (AF), although results have been mixed. To further characterize changes in AF during rotor ablation, we quantified mo ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · March 24, 2020
BACKGROUND: Atrial fibrillation (AF) is common in patients with end-stage renal disease (ESRD). The impact of oral anticoagulation (OAC) in ESRD patients is uncertain. OBJECTIVES: The purpose of this study was to describe patterns of OAC use in ESRD patien ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · March 2020
BACKGROUND: Reports on the subcutaneous implantable cardioverter-defibrillator (S-ICD) cumulatively demonstrate a low rate of complications, but clinical experience with this technology is limited compared with transvenous devices. OBJECTIVE: The purpose o ...
Full textLink to itemCite
Journal ArticleSchizophr Bull · February 26, 2020
BACKGROUND: There are limited data on electrocardiogram (ECG) characteristics and their association with psychotropic drugs in schizophrenia. METHODS: Using a cross-sectional design, we included Danish primary care patients with first-time digital ECGs fro ...
Full textLink to itemCite
Journal ArticleJ Electrocardiol · 2020
BACKGROUND: Some patients with ongoing heart failure symptoms after treatment with cardiac resynchronization therapy (CRT) demonstrate QRS prolongation during exercise. We investigated whether the optimal CRT pacing configuration changes during dobutamine ...
Full textLink to itemCite
Journal ArticlePacing Clin Electrophysiol · November 2019
BACKGROUND: PR interval prolongation is associated with poor outcome after cardiac resynchronization therapy (CRT) among patients with left bundle branch block (LBBB) but the mechanisms are unknown. We investigated clinical outcomes, electrocardiogram (ECG ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · November 2019
BACKGROUND: Changes in left ventricular (LV) activation after cardiac resynchronization therapy (CRT) influence survival but are difficult to quantify noninvasively. METHODS AND RESULTS: We studied 527 CRT patients to assess whether noninvasive quantificat ...
Full textLink to itemCite
Journal ArticleCardiovasc Ultrasound · May 21, 2019
BACKGROUND: The association of a Classical left bundle branch block (LBBB) contraction pattern and better outcome after cardiac resynchronization therapy (CRT) has only been studied using vendor-specific software for echocardiographic speckle-tracked longi ...
Full textLink to itemCite
Journal ArticleUltrasound Med Biol · May 2019
Recently, we developed a high-frame-rate echocardiographic imaging system capable of acquiring images at rates up to 2500 per second. High imaging rates were used to quantify longitudinal strain parameters in patients with echocardiographically normal func ...
Full textLink to itemCite
Journal ArticleCard Electrophysiol Clin · March 2019
Implantation of cardiac resynchronization therapy devices represents one of the more challenging and time-consuming procedures for the clinical electrophysiologist. This article reviews several strategies used to improve efficiency, safety, and effectivene ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · February 2019
BACKGROUND: Recent studies have suggested that vectorcardiographic measures predict left ventricular (LV) reverse remodeling and clinical outcome in patients receiving cardiac resynchronization therapy (CRT). OBJECTIVES: The objectives of this study were t ...
Full textLink to itemCite
Journal ArticleCirculation · December 11, 2018
BACKGROUND: Landmark studies have demonstrated the safety and efficacy of implantable cardioverter-defibrillators (ICDs) in selected stable ambulatory patients with heart failure (HF) with a reduced ejection fraction receiving optimal medical therapy. It i ...
Full textLink to itemCite
Journal ArticleCirc Arrhythm Electrophysiol · December 2018
BACKGROUND: In patients with left bundle branch block (LBBB), QRS duration (QRSd) depends on left ventricular (LV) dimension. Previously, we demonstrated that normalizing QRSd to LV dimension, to adjust for variations in LV size, improved prediction of hem ...
Full textLink to itemCite
Journal ArticleEuropace · November 1, 2018
AIMS: To assess whether obstructive sleep apnea (OSA) was associated with increased rotor burden among atrial fibrillation (AF) patients. METHODS AND RESULTS: We studied 33 consecutive patients who were scheduled for focal impulse and rotor modulation (FIR ...
Full textLink to itemCite
Journal ArticleAm Heart J · July 2018
BACKGROUND: Left ventricular ejection fraction (LVEF) is used to select patients for primary prevention implantable cardioverter defibrillators (ICDs). The relationship between baseline and long-term follow-up LVEF and clinical outcomes among primary preve ...
Full textLink to itemCite
Journal ArticleCirculation · June 5, 2018
BACKGROUND: Compared with transvenous implantable cardioverter defibrillators (ICDs), subcutaneous (S)-ICDs require a higher energy for effective defibrillation. Although ventricular fibrillation conversion testing (CT) is recommended after S-ICD implantat ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · June 2018
BACKGROUND: This study compares early and late outcomes in patients undergoing coronary artery bypass grafting with and without preoperative atrial fibrillation in a contemporary, nationally representative Medicare cohort. METHODS: In the Medicare-Linked S ...
Full textLink to itemCite
Journal ArticleEur J Heart Fail · June 2018
AIM: There is limited information on the outcomes after primary prevention implantable cardioverter-defibrillator (ICD) implantation in patients with heart failure (HF) and diabetes. This analysis evaluates the effectiveness of a strategy of ICD plus medic ...
Full textLink to itemCite
Journal ArticleCard Electrophysiol Clin · March 2018
The implantable cardioverter defibrillator (ICD) is a life-saving therapy in various patient populations. Although data on the outcomes of initial ICD implants are abundant, data on ICD replacements, especially in patients with improved left ventricular (L ...
Full textLink to itemCite
Journal ArticleJAMA · January 23, 2018
IMPORTANCE: The left atrial appendage is a key site of thrombus formation in atrial fibrillation (AF) and can be occluded or removed at the time of cardiac surgery. There is limited evidence regarding the effectiveness of surgical left atrial appendage occ ...
Full textLink to itemCite
Journal ArticleJACC Clin Electrophysiol · January 2018
OBJECTIVES: In this study, the authors sought to perform a meta-analysis of controlled studies assessing the relationship between left atrial appendage (LAA) electrical isolation (EI) and recurrent atrial fibrillation (AF). BACKGROUND: LAA triggers could p ...
Full textLink to itemCite
Journal ArticleJ Electrocardiol · 2018
Cardiac resynchronization therapy (CRT) has revolutionized the care of patients with heart failure with reduced ejection fraction (HFrEF) and left bundle branch block (LBBB); some hypothesize that electrical resynchronization may also benefit patients with ...
Full textLink to itemCite
ConferenceJ Cardiovasc Electrophysiol · November 2017
BACKGROUND: No precise tools exist to predict appropriate shocks in patients with a primary prevention ICD. We sought to identify characteristics predictive of appropriate shocks in patients with a primary prevention implantable cardioverter defibrillator ...
Full textLink to itemCite
ConferenceAm Heart J · September 2017
BACKGROUND: Primary prevention implantable cardioverter defibrillator (ICD) reduce all-cause mortality by reducing sudden cardiac death. There are conflicting data regarding whether patients with more advanced heart failure derive ICD benefit owing to the ...
Full textLink to itemCite
Journal ArticleCurrent Cardiovascular Risk Reports · September 1, 2017
Purpose of Review: Although the risk of sudden cardiac death is high in patients with end-stage renal disease (ESRD), it is not clear if such patients benefit from the implantable cardioverter defibrillator (ICD). This paper reviews data on the risk of sud ...
Full textCite
Journal ArticleJ Am Heart Assoc · August 23, 2017
BACKGROUND: Prior studies have demonstrated a link between the metabolic syndrome and increased risk of cardiovascular mortality. Whether the metabolic syndrome is associated with sudden cardiac death is uncertain. METHODS AND RESULTS: We characterized the ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · May 16, 2017
BACKGROUND: Data regarding cardiac resynchronization therapy (CRT) in patients with multiple comorbidities are limited. OBJECTIVES: This study evaluated the association of multiple comorbidities with the benefits of CRT over implantable cardioverter-defibr ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · March 15, 2017
Implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy (CRT) reduce mortality in many patients with heart failure (HF), but the current use and effectiveness of ICD/CRT in patients with chronic kidney disease (CKD) are uncertai ...
Full textLink to itemCite
Journal ArticleCirculation · November 22, 2016
BACKGROUND: A prolonged PR interval is common among cardiac resynchronization therapy (CRT) candidates; however, the association between PR interval and outcomes is unclear, and the data are conflicting. METHODS: We conducted inverse probability weighted a ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · November 2016
We present a case of a patient with elevated His lead capture thresholds and intermittent recruitment of the left bundle. The patient underwent a noninvasive electrophysiology study and was determined to have a left bundle branch block due to postrepolariz ...
Full textLink to itemCite
Journal ArticleJAMA Cardiol · November 1, 2016
IMPORTANCE: Trends and in-hospital outcomes associated with early adoption of the subcutaneous implantable cardioverter defibrillator (S-ICD) in the United States have not been described. OBJECTIVES: To describe early use of the S-ICD in the United States ...
Full textLink to itemCite
Journal ArticleJ Interv Card Electrophysiol · October 2016
The evolving healthcare environment demands optimally measured quality of care. Performance measures are increasingly being used for quality improvement, public reporting, and reimbursement determinations. The National Quality Forum has created rigorous cr ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · August 2016
Catheter ablation of ventricular tachycardia (VT) has evolved in recent years, especially in patients with ischemic heart disease. Data from prospective studies show that VT catheter ablation reduces the risk of recurrent VT; however, there is a paucity of ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · December 15, 2015
BACKGROUND: Patients with moderate-to-severe chronic kidney disease (CKD) are poorly represented in clinical trials of cardiac resynchronization therapy (CRT). OBJECTIVES: This study sought to assess the real-world comparative effectiveness of CRT with def ...
Full textLink to itemCite
Journal ArticlePacing Clin Electrophysiol · October 2015
BACKGROUND: Chronic kidney disease (CKD) severity is associated with increased morbidity and mortality in congestive heart failure. There is a paucity of data regarding renal improvement after cardiac resynchronization therapy (CRT) and its potential impac ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · June 2015
BACKGROUND: Cardiac resynchronization therapy (CRT) has been shown to reduce mitral regurgitation (MR), although the clinical impact of this improvement remains uncertain. OBJECTIVES: We sought to evaluate the impact of MR improvement on clinical outcome a ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · November 2014
BACKGROUND: Cardiac resynchronization therapy (CRT) nonresponders have poor outcomes. The significance of progressive ventricular dysfunction among nonresponders remains unclear. OBJECTIVE: We sought to define predictors of and clinical outcomes associated ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · March 4, 2014
BACKGROUND: Obesity is associated with altered atrial electrophysiology and a prominent risk factor for atrial fibrillation. Body mass index, the most widely used adiposity measure, has been related to atrial electrical remodeling. We tested the hypothesis ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · November 15, 2013
Cardiac resynchronization therapy (CRT) is often deferred in dialysis-dependent patients with heart failure (HF) because of a perceived lack of benefit and potentially higher risks, although the outcomes associated with CRT in dialysis have not been report ...
Full textLink to itemCite
Journal ArticleAnn Noninvasive Electrocardiol · July 2013
BACKGROUND: Although ECG left ventricular hypertrophy (LVH) by Cornell product (CP) predicts increased mortality in patients with ischemic cardiomyopathy (ICM), those without CP LVH remain at relatively high risk. We examined whether T-wave alternans (TWA) ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · May 2013
BACKGROUND: Both anatomic and electrical locations of the left ventricular (LV) lead have been identified as important predictors of clinical outcomes in cardiac resynchronization therapy (CRT). The impact of LV lead location on incident device-treated ven ...
Full textLink to itemCite
Journal ArticleJ Interv Card Electrophysiol · September 2012
PURPOSE: The relatively low incidence of device-treated ventricular arrhythmias in patients with ischemic cardiomyopathy (ICM) who receive implantable cardioverter defibrillators (ICDs) for primary prevention makes improved risk stratification of ICM patie ...
Full textLink to itemCite
Journal ArticleCirc Arrhythm Electrophysiol · August 1, 2012
BACKGROUND: Patients undergoing cardiac resynchronization therapy (CRT) are at high risk for ventricular arrhythmias (VAs), and risk stratification in this population remains poor. METHODS AND RESULTS: This study followed 269 patients (left ventricular eje ...
Full textLink to itemCite